The Union health ministry has proposed an amendment to the New Drugs and Clinical Trials Rules, 2019, that would require manufacturers of antimicrobials to obtain central permission before they can apply to a state for a manufacturing licence
Antimicrobial makers may need Centre’s nod before seeking licences
Published ·

Keep reading
Related stories









